Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 3/2009

01-06-2009 | Original Paper

A Test of Motivational Plus Nicotine Replacement Interventions for HIV Positive Smokers

Authors: Karen S. Ingersoll, Karen L. Cropsey, Carolyn J. Heckman

Published in: AIDS and Behavior | Issue 3/2009

Login to get access

Abstract

The purpose of this study was to test two combination motivational plus pharmacological interventions for smoking cessation among HIV positive smokers. Participants were 40 adults receiving HIV care who smoked daily reporting interest in smoking reduction. Measures were administered at baseline, 1-month, and 3-month follow-ups. Participants were randomly assigned to self-guided reading plus nicotine patch (n = 18) or motivational interviewing plus nicotine patch (n = 22). Groups did not differ at 3 months on biochemically-verified abstinence. The sample reduced cigarettes per day by half a pack and the percent of smoking days by 41%, and 22% were abstinent at 3-month follow-up. Compliance with the nicotine patch was poor and declined over time, but patch use was unrelated to carbon monoxide level at 3-month follow-up. Smoking cessation interventions for people with HIV can be helpful and should include components that encourage some smoke-free days, increase self-efficacy, and attend to adherence to nicotine replacement treatment.
Literature
Alterman, A. I., Gariti, P., Cook, T. G., & Cnaan, A. (1999). Nicodermal patch adherence and its correlates. Drug and Alcohol Dependence, 53, 159–165.PubMedCrossRef
Amodei, N., & Lamb, R. J. (2005). Predictors of initial abstinence in smokers enrolled in a smoking cessation program. Substance Use and Misuse, 40, 141–149.PubMedCrossRef
Aubin, H. J., Lebargy, F., Berlin, I., Bidaut-Mazel, C., Chemali-Hudry, J., & Lagrue, G. (2004). Efficacy of bupropion and predictors of successful outcome in a sample of French smokers: A randomized placebo-controlled trial. Addiction, 99, 1206–1218.PubMedCrossRef
Bandura, A. (1977). Self-efficacy: Toward a unifying theory of behavioral change. Psychological Review, 84, 191–215.PubMedCrossRef
Bohn M. J., Babor T. F., & Kranzler, H. R. (1995). The alcohol use disorders identification test (AUDIT): Validation of a screening instrument for use in medical settings. Journal of Studies on Alcohol, 56, 423–432.PubMed
Budney, A. J., Higgins, S. T., Hughes, J. R., Bickel, W. K. (1993). Nicotine and caffeine use in cocaine-dependent individuals. Journal of Substance Abuse, 5, 117–130.PubMedCrossRef
Burns, D. N., Hillman, D., Neaton, J. D., Sherer, R., Mitchell, T., Capps, L., et al. (1996). Cigarette smoking, bacterial pneumonia, and other clinical outcomes in HIV-1 infection. Terry Beirn community programs for clinical research on AIDS. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 13, 374–383.PubMed
Chaisson, R. E. (1994). Smoking cessation in patients with HIV. Journal of the American Medical Association, 272, 564.PubMedCrossRef
Cooper, T. V., DeBon, M. W., Stockton, M., Klesges, R. C., Steenbergh, T. A., Sherrill-Mittleman, D., Jennings, L. C., & Johnson, K. C. (2004). Correlates of adherence with transdermal nicotine. Addictive Behaviors, 29, 1565–1578.PubMedCrossRef
Cropsey, K., Eldridge, G. D., & Ladner, T. (2004). Smoking among female prisoners: An ignored public health epidemic. Addictive Behaviors, 29, 426–431.CrossRef
Cropsey, K. L., Eldridge, G. D., Weaver, M. F., Villalobos, G. C., & Stitzer, M. L. (2006). Expired carbon monoxide levels in self-reported smokers and nonsmokers in prison. Nicotine and Tobacco Research, 8, 653–659.PubMedCrossRef
Cummings, K. M., & Hyland, A. (2005). Impact of nicotine replacement therapy on smoking behavior. Annual Review of Public Health. 26, 583–599.PubMedCrossRef
Diaz, P. T., King, M. A., Pacht, E. R., Wewers, M. D., Gadek, J. E., Nagaraja, H. N., Drake, J., & Clanton, T. L. (2000). Increased susceptibility to pulmonary emphysema among HIV-seropositive smokers. Annals of Internal Medicine, 132, 369–372.PubMed
DiClemente, C. C., Prochaska, J. O., Fairhurst, S., Velicer, W. F., Rossi J. S., & Velasquez, M. (1991). The process of smoking cessation: An analysis of precontemplation, contemplation and contemplation/action. Journal of Consulting and Clinical Psychology, 59, 295–304.PubMedCrossRef
Feenstra, T. L., Hamberg-van Reenan, H. H., Hoogenveen, R. T., & Rutten-van Molken, M. P. M. H. (2005). Cost-effectiveness of face-to-face smoking cessation interventions: a dynamic modeling study. Value in Health, 8, 178–190.PubMedCrossRef
Fiore, M. C. (2000). Treating tobacco use and dependence: An evidence based clinical practice guideline for tobacco cessation. Rockville, MD: U.S. Department of Health and Human Services.
Heatherton, T. F., Kozlowski, L. T., Frecker, R. C., Fagerstrom, K. O. (1991). The Fagerstrom test for nicotine dependence: A revision of the Fagerstrom tolerance questionnaire. British Journal of Addiction, 86, 1119–1127.PubMedCrossRef
Hughes, J. R., Callas, P. W., & Peters, E. N. (2007). Interest in gradual cessation. Nicotine and Tobacco Research, 9, 671–675.PubMedCrossRef
Hughes, J. R., & Carpenter, M. J. (2006). Does smoking reduction increase future cessation and decrease disease risk? A qualitative review. Nicotine and Tobacco Research, 8, 739–749.PubMedCrossRef
Hughes, J. R., & Hatsukami, D. (1986). Signs and symptoms of tobacco withdrawal. Archives of General Psychiatry, 43, 289–294.PubMed
Ingersoll, K. S. (2004). The impact of psychiatric symptoms, drug use, and medication regimen on non-adherence to HIV medication. AIDS Care. 16, 199–211.PubMedCrossRef
Ingersoll, K. S., & Cohen, J. (2005). Combination treatment for nicotine dependence: State of the science. Substance Use and Misuse, 40, 1923–1943.PubMedCrossRef
Ingersoll, K. S., & Heckman-Stone, C. J. (2005). Patient-clinician relationships and treatment system effects on HIV medication adherence. AIDS and Behavior, 9, 89–101.PubMedCrossRef
Kessler, R. C., Barker, P. R., Colpe, L. J., Epstein, J. F., Gfroerer, J. C., Hiripi, E., Howes, M. J., Normand, S. L., Manderscheid, R. W., Walters, E. E., & Zaslavsky, A. M. (2003). Screening for serious mental illness in the general population. Archives of General Psychiatry, 60, 184–189.PubMedCrossRef
Killen, J. D., Fortmann, S. P., Newman, B., & Varady, A. (1990). Evaluation of a treatment approach combining nicotine gum with self-guided behavioral treatments for smoking relapse prevention. Journal of Consulting and Clinical Psychology, 58, 85–92.PubMedCrossRef
Mamary, E. M., Bahrs, D., & Martinez, S. (2002). Cigarette smoking and the desire to quit among individuals living with HIV. AIDS Patient Care and STDs, 16, 39–42.PubMedCrossRef
Miller, W. R., & Rollnick, S. (2002). Motivational interviewing: Preparing people for change (2nd ed.). New York: The Guilford Press.
Niaura, R., Shadel, W. G., Morrow, K., Tashima, K., Flanigan, T., & Abrams, D. B. (2000). Human immunodeficiency virus infection, AIDS, and smoking cessation: The time is now. Clinical Infectious Diseases, 31, 808–812.PubMedCrossRef
Nieman, R. B., Coker, R. J., & Mitchell, D. M. (1993). Cigarette smoking, leukocyte profiles, and HIV-1 progression. Journal of Acquired Immune Deficiency Syndrome, 6, 1174–1176.
O’Hea, E. L., Boudreaux, E. D., Jeffries, S. K., Taylor, C. L., Scarinci, I. C., & Brantley, P. J. (2004). Stage of change movement across three health behaviors: The role of self-efficacy. American Journal of Health Promotion, 19, 94–102.PubMed
Okuyemi, K. S., James, A. S., Mayo, M. S., Nollen, N., Catley, D., Choi, W. S., & Ahluwalia, J. S. (2007). Pathways to health: A cluster randomized trial of nicotine gum and motivational interviewing for smoking cessation in low-income housing. Health Education and Behavior, 34, 43–54.PubMedCrossRef
Palacio, H., Hilton, J. F., Canchola, A. J., & Greenspan, D. (1997). Effect of cigarette smoking on HIV-related oral lesions. Journal of Acquired Immune Deficiency Syndrome and Human Retrovirology, 14, 338–342.
Phelps, R. M., Smith, D. K., Heilig, C. M., Gardner, L. I., Carpenter, C. C., Klein, R. S., et al. (2001). Cancer incidence in women with or at risk for HIV. International Journal of Cancer, 94, 753–757.CrossRef
Pisinger, C., & Godtfredsen, N. S. (2007). Is there a health benefit of reduced tobacco consumption? A systematic review. Nicotine and Tobacco Research, 9, 631–646.PubMedCrossRef
Prochaska, J. O., & DiClemente, C. C. (1983). Stages and processes of self-change of smoking: Toward an integrative model of change. Journal of Consulting and Clinical Psychology, 51, 390–395.PubMedCrossRef
Prochaska, J. O., Velicer, W. F., DiClemente, C. C., & Fava, J. L. (1988). Measuring the processes of change: Applications to the cessation of smoking. Journal of Consulting and Clinical Psychology, 56, 520–528.PubMedCrossRef
Radloff, L. W. (1977). The CES-D scale: A self-report scale for research in the general population. Applied Psychological Measurement, 1, 385–401.CrossRef
Richter, K. P., McCool, R. M., Catley, D., Hall, M., & Ahluwalia, J. S. (2005). Dual pharmacotherapy and motivational interviewing for tobacco dependence among drug treatment patients. Journal of Addictive Diseases, 24, 79–90.PubMedCrossRef
Rollnick, S., Mason, P., & Butler, C. (1999). Health behavior change. London: Churchill Livingstone.
Schumann, A., Meyer, C., Rumpf, H.-J., Hannover, W., Hapke, U, & John, U. (2005). Stage of change transitions and processes of change, decisional balance, and self-efficacy in smokers: A transtheoretical model validation using longitudinal data. Psychology of Addictive Behaviors, 19, 3–9.PubMedCrossRef
Sobell, L. C., Cunningham, J. A., & Sobell, M. B. (1996). Fostering self-change among problem drinkers: A proactive community intervention. Addictive Behaviors, 21, 817–833.PubMedCrossRef
Sobell, L. C., & Sobell, M. B. (1992). Timeline follow-back: A technique for assessing self-reported alcohol consumption. In R. Z. Litten, & J. Allen (Eds.), Measuring alcohol consumption: Psychosocial and biological methods (pp. 41–72). New Jersey: Humana Press.
Sobell, M. B., & Sobell, L. C. (1993). Problem drinkers: Guided self-change treatment. New York: Guilford Press.
Sobell, M. B., & Sobell, L. C. (1998). Guiding self-change in treating addictive behaviors. In W. R. Miller, & N. Heather (Eds.), Treating addictive behaviors: Processes of change (pp. 189–202). New York: Plenum Press.
Sobell, L. C., Sobell, M. B., & Leo, G. I. (2002). Promoting self-change with alcohol abusers: A community-level mail intervention based on natural recovery studies. Alcoholism: Clinical and Experimental Research, 26, 936–948.
Soria, R., Legido, A., Escolano, C., Lopez Yeste, A., & Montoya, J. (2006). A randomised controlled trial of motivational interviewing for smoking cessation. British Journal of General Practice, 56, 768–774.PubMed
Sutton, S., & Gilbert, H. (2007). Effectiveness of individually tailored smoking cessation advice letters as an adjunct to telephone counseling and generic self-help materials: Randomized controlled trial. Addiction, 102, 994–1000.PubMedCrossRef
Tappin, D. M., Lumsden, M. A., McIntyre, D., McKay, C., Gilmour, W. H., Webber, R., Cowan, S., Crawford, F., & Currie, F. (2000). A pilot study to establish a randomized trial methodology to test the efficacy of a behavioural intervention. Health Education Research, 15, 491–502.PubMedCrossRef
Thyrian, J. R., Freyer-Adam, J., Hannover, W., Roske, K., Mentzel, F., Kufeld, C., et al. (2007). Adherence to the principles of motivational interviewing, clients’ characteristics and behavior outcome in a smoking cessation and relapse prevention trial in women postpartum. Addictive Behaviors, 32, 2297–2303.PubMedCrossRef
Turner, J., Page-Shafer, K., Chin, D. P., Osmond, D., Mossar, M., Markstein, L., et al. (2001). Adverse impact of cigarette smoking on dimensions of health-related quality of life in persons with HIV infection. AIDS Patient Care and STDs, 15, 615–624.PubMedCrossRef
Uyar, M., Filiz, A., Bayram, N., Elbek, O., Herken, H., Topen, A., Dikensoy O., & Ekinci, E. (2007). A randomized trial of smoking cessation. Medication vs. motivation. Saudi Medical Journal, 28, 922–926.PubMed
Velicer, W. F., DiClemente, C. C., Rossi, J. S., & Prochaska, J. O. (1990). Relapse situations and self-efficacy: An integrative model. Addictive Behaviors, 15, 271–283.PubMedCrossRef
Velicer, W. F., DiClemente, C. C., Prochaska, J. O., & Brandenberg, N. (1985). A decisional balance measure for assessing and predicting smoking status. Journal of Personality and Social Psychology, 48, 1279–1289.PubMedCrossRef
Vidrine, D. J., Arduino, R. C., Lazev, A. B., & Gritz, E. R. (2006). A randomized trial of a proactive cellular telephone intervention for smokers living with HIV/AIDS. AIDS, 20, 253–260.PubMedCrossRef
Wakefield, M., Olver, I., Whitford, H., & Rosenfeld, E. (2004). Motivational interviewing as a smoking cessation intervention for patients with cancer: Randomized controlled trial. Nursing Research, 53, 396–405.PubMedCrossRef
West, R., Hajek, P., Stead, L., & Stapleton, J. (2005). Outcome criteria in smoking cessation trials: Proposal for a common standard. Addiction, 100, 299–303.PubMedCrossRef
Metadata
Title
A Test of Motivational Plus Nicotine Replacement Interventions for HIV Positive Smokers
Authors
Karen S. Ingersoll
Karen L. Cropsey
Carolyn J. Heckman
Publication date
01-06-2009
Publisher
Springer US
Published in
AIDS and Behavior / Issue 3/2009
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-007-9334-4

Other articles of this Issue 3/2009

AIDS and Behavior 3/2009 Go to the issue

Commentary

Broadening Research on Microfinance and Related Strategies for HIV Prevention: Commentary on Dworkin and Blankenship (2009)

Original Paper

Latinos and HIV/AIDS: Examining Factors Related to Disparity and Identifying Opportunities for Psychosocial Intervention Research

Original Research

Microfinance and HIV/AIDS Prevention: Assessing its Promise and Limitations

Review Paper

HIV/AIDS Behavioral Interventions in China: A Literature Review and Recommendation for Future Research

Original Paper

Effects of Micro-Enterprise Services on HIV Risk Behaviour Among Female Sex Workers in Kenya’s Urban Slums

Report

An Agenda for Advancing the Science of Implementation of Evidence-Based HIV Prevention Interventions
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits